Contributor Disclosures for Giant Cell Arteritis

Role Name Disclosure Details Author  Stephen A Paget, MD, Chair, Division of Rheumatology, Chief, Department of Medicine, Hospital for Special Surgery; Professor, Department of Internal Medicine, Division of Rheumatology, Weill-Cornell University Nothing to disclose Details Coauthor  Evan Leibowitz, MD, Fellow, Department of Internal Medicine, Division of Rheumatology, Valley Hospital Nothing to disclose Details Medical Editor  John Varga, MD, Professor, Department of Internal Medicine, Division of Rheumatology, Northwestern University Nothing to disclose Details Pharmacy Editor  Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine Nothing to disclose Details Managing Editor  Lawrence H Brent, MD, Associate Professor of Medicine, Thomas Jefferson University; Chair, Program Director, Department of Medicine, Division of Rheumatology, Albert Einstein Medical Center Genentech Genentch Genentech Abbott Immunology Amgen Wyeth Details CME Editor  Alex J Mechaber, MD, FACP, Assistant Dean for Medical Curriculum, Associate Professor of Medicine, Division of General Internal Medicine, University of Miami Miller School of Medicine Nothing to disclose Details Chief Editor  Arthur Weinstein, MD, Professor of Medicine, Georgetown University Medical Center; Associate Chairman, Department of Medicine, Director, Section of Rheumatology, Washington Hospital Center Nothing to disclose Details Contributor Disclosure Contributor: Contributor Disclosure: Stephen A Paget, Author  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Evan Leibowitz, Coauthor  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: John Varga, Medical Editor  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Francisco Talavera  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication CONTRIBUTOR DISCLOSURE FORM Contributor Name: Lawrence H Brent  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Genentech Honoraria Speaking and teaching   Genentch Honoraria Consulting   Genentech Grant/research funds Other   Abbott Immunology Honoraria Speaking and teaching   Amgen Honoraria Speaking and teaching   Wyeth Honoraria Speaking and teaching   Off label or investigational use of medication CONTRIBUTOR DISCLOSURE FORM Contributor Name: Alex J Mechaber  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication Contributor Disclosure Contributor: Contributor Disclosure: Arthur Weinstein, Chief Editor  The contributor discloses no conflict of interest.